Safety and efficacy of oral DMSA therapy for children with autismspectrum disorders: Part A -- Medical results.
- Published in:
- BMC Clinical Pharmacology, 2009, v. 9, p. 16, doi. 10.1186/1472-6904-9-16
- Publication type:
- Article
Works matching IS 14726904 AND DT 2009 AND VI 9
Results: 22
1
2
Methanol poisoning and long term sequelae - a six years follow-up after a large methanol outbreak.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
3
Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part A--medical results.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
4
Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B - behavioral results.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
5
A glycosylated recombinant human granulocyte colony stimulating factor produced in a novel protein production system (AVI-014) in healthy subjects: a first-in human, single dose, controlled study.
- Published in:
- BMC Clinical Pharmacology, 2009, v. 9, p. 2, doi. 10.1186/1472-6904-9-2
- Publication type:
- Article
6
Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people.
- Published in:
- BMC Clinical Pharmacology, 2009, v. 9, p. 6, doi. 10.1186/1472-6904-9-6
- Publication type:
- Article
7
Bioavailability of ibuprofen following oral administration ofstandard ibuprofen, sodium ibuprofen or ibuprofen acidincorporating poloxamer in healthy volunteers.
- Published in:
- BMC Clinical Pharmacology, 2009, v. 9, p. 19, doi. 10.1186/1472-6904-9-19
- Publication type:
- Article
8
In vivo administration of BL-3050: highly stable engineeredPON1-HDL complexes.
- Published in:
- BMC Clinical Pharmacology, 2009, v. 9, p. 18, doi. 10.1186/1472-6904-9-18
- Publication type:
- Article
9
Safety and efficacy of oral DMSA therapy for children with autismspectrum disorders: Part B -- Behavioral results.
- Published in:
- BMC Clinical Pharmacology, 2009, v. 9, p. 17, doi. 10.1186/1472-6904-9-17
- Publication type:
- Article
10
Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics.
- Published in:
- BMC Clinical Pharmacology, 2009, v. 9, p. 1, doi. 10.1186/1472-6904-9-1
- Publication type:
- Article
11
Evaluation of risk factor management of patients treated on an internal nephrology ward: a pilot study.
- Published in:
- BMC Clinical Pharmacology, 2009, v. 9, p. 15, doi. 10.1186/1472-6904-9-15
- Publication type:
- Article
12
A Phase 1 Trial of pharmacologic interactions between transdermalselegiline and a 4-hour cocaine infusion.
- Published in:
- BMC Clinical Pharmacology, 2009, v. 9, p. 13, doi. 10.1186/1472-6904-9-13
- Publication type:
- Article
13
Perceptions of doctors to adverse drug reaction reporting in ateaching hospital in Lagos, Nigeria.
- Published in:
- BMC Clinical Pharmacology, 2009, v. 9, p. 14, doi. 10.1186/1472-6904-9-14
- Publication type:
- Article
14
Errors and omissions in hospital prescriptions: a survey of prescription writing in a hospital.
- Published in:
- BMC Clinical Pharmacology, 2009, v. 9, p. 1, doi. 10.1186/1472-6904-9-9
- By:
- Publication type:
- Article
15
The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty.
- Published in:
- BMC Clinical Pharmacology, 2009, v. 9, p. 1, doi. 10.1186/1472-6904-9-8
- By:
- Publication type:
- Article
16
Fatal drug poisonings in a Swedish general population.
- Published in:
- BMC Clinical Pharmacology, 2009, v. 9, p. 1, doi. 10.1186/1472-6904-9-7
- By:
- Publication type:
- Article
17
Methanol poisoning and long term sequelae -- a six years follow-up after a large methanol outbreak.
- Published in:
- BMC Clinical Pharmacology, 2009, v. 9, p. 1, doi. 10.1186/1472-6904-9-5
- By:
- Publication type:
- Article
18
Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs.
- Published in:
- BMC Clinical Pharmacology, 2009, v. 9, p. 1, doi. 10.1186/1472-6904-9-4
- By:
- Publication type:
- Article
19
Clinical outcomes and kinetics of propanil following acute self-poisoning: a prospective case series.
- Published in:
- 2009
- By:
- Publication type:
- Case Study
20
Effect of buspirone on thermal sensory and pain thresholds in human volunteers.
- Published in:
- BMC Clinical Pharmacology, 2009, v. 9, p. 1, doi. 10.1186/1472-6904-9-12
- By:
- Publication type:
- Article
21
Dispensed drugs and multiple medications in the Swedish population: an individual-based register study.
- Published in:
- BMC Clinical Pharmacology, 2009, v. 9, p. 1, doi. 10.1186/1472-6904-9-11
- By:
- Publication type:
- Article
22
Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple intravenous administrations: an open-label randomised controlled trial.
- Published in:
- BMC Clinical Pharmacology, 2009, v. 9, p. 1, doi. 10.1186/1472-6904-9-10
- By:
- Publication type:
- Article